The Ozempic Patent Dispute: Was Semaglutide Really a New Invention? Novo Nordisk v. Dr. Reddy’s Laboratories

PATHtoIP cover graphic: “The Ozempic Patent Dispute: Was Semaglutide Really a New Invention?” Novo Nordisk v. Dr. Reddy’s, with Delhi High Court gavel and Ozempic pen.
Novo Nordisk v. Dr. Reddy’s Laboratories: the Delhi High Court examined whether semaglutide was a genuinely new invention or an obvious step from an earlier patent.

Introduction The Ozempic Patent Dispute began in India, where a fight over who could make semaglutide, the active ingredient behind Ozempic, Wegovy and Rybelsus, ended up in the Delhi High Court. At stake was ...

Read More
Categories: Indian Patent Law Patent infringement

What Is the Budapest Treaty? How to Patent an Invention You Cannot Fully Describe in Words

Gloved hand holding a petri dish beside test tubes and a world map, with the title “What Is the Budapest Treaty?”
The Budapest Treaty lets biotech inventors deposit a microorganism once and have it recognised for patent purposes across member countries.

Introduction A patent is a trade: you disclose your invention in enough detail that others could reproduce it, and in return you get exclusive rights. For a machine or a chemical ...

Read More
Categories: Patent

Software Patentability in India: How Ferid Allani and Robert Bosch Shaped Section 3(k) and 3(m)

Software Patentability in India cover graphic showing a laptop with code, Section 3(k) and 3(m) labels, the Indian Patents Act, scales of justice and an India map.
Ferid Allani and Robert Bosch: the two rulings that clarified when software and technical method inventions can be patented in India.

Introduction Software patentability in India has long been a grey area, but two landmark rulings, Ferid Allani v. Deputy Controller of Patents and Designs (2025) have made the rules much clearer for software a...

Read More
Categories: Patent Patentability

Section 3 of the Indian Patents Act: What Biotech and Microbiology Inventions Can’t Patent

Section 3 of the Indian Patents Act
Section 3 of the Indian Patents Act decides which biotech and microbiology inventions can be patented in India. Key clauses, real cases, practical guidance.

Introduction Not every invention that is scientifically valuable can be patented in India, and Section 3 of the Indian Patent Act, 1970 is where many biotech and microbiology applications first run into troubl...

Read More
Categories: Indian patent act Indian Patent Law

Blocking Patents & Freedom to Operate: What Innovators Should Know

Feature image titled “Blocking Patents & Freedom to Operate (FTO): What Innovators Should Know”. On the left, patent documents, a microneedle patch and a magnifying glass over a numbered claims list. On the right, a “Blocking Patent” wall with a barrier and no-entry sign, and a signpost pointing to License, Design Around, Challenge and Wait for Expiry.
A blocking patent isn’t the end of the road. Licensing, designing around, challenging the patent or waiting for expiry can each keep a launch moving.

Introduction Owning a patent does not mean you are free to sell the product it covers. A patent gives you the right to stop others from making, using or selling your invention. It does not by itself give you t...

Read More
Categories: Patent Terminologies Freedom-To-Operate

Patent Term Adjustment in India: Why the Supreme Court’s Latest Case Matters

Patent Term Adjustment in India
Patent Term Adjustment in India: the Supreme Court examines whether patentees should be compensated for grant delays.

How Is the Patent Term Calculated Under Indian Patent Law? A patent is a time-limited monopoly, and every day of that term has commercial value. But what if a large part of it is spent waiting for the patent o...

Read More
Categories: Indian Patent Law